Adding oral albuterol to glatiramer injections appears to enhance the clinical response of multiple sclerosis patients during the first year of therapy, according to a report in the September issue of the Archives of Neurology.
Adding oral albuterol to glatiramer injections appears to enhance the clinical response of multiple sclerosis patients during the first year of therapy, according to a report in the September issue of the Archives of Neurology.